Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation

Authors

  • Ugyen Zangmo Jigme Dorji Wangchuk National Referral Hospital, Thimphu, Bhutan
  • Sushma Jayanna Shantilal Shanghvi Eye Institute, Mumbai, India https://orcid.org/0000-0002-4020-2147
  • Mahesh P Shanmugam Sankara Eye Foundation, Bangalore, India

Keywords:

avastin, failed macular hole closure, secondary macular hole

Abstract

Background: Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.

Case: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.

Observations: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention. 

Conclusion: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.

Abstract
362
PDF
0

Downloads

Published

2023-12-31

How to Cite

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation. (2023). Nepalese Journal of Ophthalmology, 15(2), 97-101. https://doi.org/10.3126/nepjoph.v15i2.55033

Issue

Section

Case Reports

How to Cite

Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation. (2023). Nepalese Journal of Ophthalmology, 15(2), 97-101. https://doi.org/10.3126/nepjoph.v15i2.55033